Andrea Altieri

Moscow, MOW 119991, Russian Federation

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

Novel anti-prion compounds screening in prion-infected cell culture model combined with surface plasmon resonance analysis.

Novel anti-prion compounds screening in prion-infected cell culture model combined with surface plasmon resonance analysis.

Journal: Scientific reports

Published: July 29, 2025

Antiviral Activity and Crystal Structures of HIV-1 gp120 Antagonists.

Antiviral Activity and Crystal Structures of HIV-1 gp120 Antagonists.

Journal: International journal of molecular sciences

Published: November 22, 2022

Comparative Pharmacokinetics of a Dual Inhibitor of HIV-1, NBD-14189, in Rats and Dogs with a Proof-of-Concept Evaluation of Antiviral Potency in SCID-hu Mouse Model.

Comparative Pharmacokinetics of a Dual Inhibitor of HIV-1, NBD-14189, in Rats and Dogs with a Proof-of-Concept Evaluation of Antiviral Potency in SCID-hu Mouse Model.

Journal: Viruses

Published: September 19, 2022

Design and Synthesis of Fsp3-Enriched Spirocyclic-Based Biological Screening Compound Arrays via DOS Strategies and Their NNMT Inhibition Profiling.

Design and Synthesis of Fsp3-Enriched Spirocyclic-Based Biological Screening Compound Arrays via DOS Strategies and Their NNMT Inhibition Profiling.

Journal: ChemMedChem

Published: July 18, 2022

Design, Synthesis, and Antiviral Activity of the Thiazole Positional Isomers of a Potent HIV-1 Entry Inhibitor NBD-14270.

Design, Synthesis, and Antiviral Activity of the Thiazole Positional Isomers of a Potent HIV-1 Entry Inhibitor NBD-14270.

Journal: ChemMedChem

Published: June 30, 2022

Design and Characterization of Novel Small Molecule Activators of Excitatory Amino Acid Transporter 2.

Design and Characterization of Novel Small Molecule Activators of Excitatory Amino Acid Transporter 2.

Journal: ACS medicinal chemistry letters

Published: June 30, 2022

Structure-Based Identification and Biological Characterization of New NAPRT Inhibitors.

Structure-Based Identification and Biological Characterization of New NAPRT Inhibitors.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: June 21, 2022

Targeting Virus-Induced Reprogrammed Cell Metabolism via Glycolytic Inhibitors: An Effective Therapeutic Approach Against SARS-CoV-2.

Targeting Virus-Induced Reprogrammed Cell Metabolism via Glycolytic Inhibitors: An Effective Therapeutic Approach Against SARS-CoV-2.

Journal: Mini reviews in medicinal chemistry

Published: March 11, 2022

Discovery of the 4-aminopiperidine-based compound EM127 for the site-specific covalent inhibition of SMYD3.

Discovery of the 4-aminopiperidine-based compound EM127 for the site-specific covalent inhibition of SMYD3.

Journal: European journal of medicinal chemistry

Published: January 24, 2022

In Vitro and In Vivo Pharmacological Characterization of a Novel TRPM8 Inhibitor Chemotype Identified by Small-Scale Preclinical Screening.

In Vitro and In Vivo Pharmacological Characterization of a Novel TRPM8 Inhibitor Chemotype Identified by Small-Scale Preclinical Screening.

Journal: International journal of molecular sciences

Published: December 31, 2021

Correction to "HIV-1 gp120 Antagonists Also Inhibit HIV-1 Reverse Transcriptase by Bridging the NNRTI and NRTI Sites".

Correction to "HIV-1 gp120 Antagonists Also Inhibit HIV-1 Reverse Transcriptase by Bridging the NNRTI and NRTI Sites".

Journal: Journal of medicinal chemistry

Published: December 17, 2021

Discovery of Highly Potent Fusion Inhibitors with Potential Pan-Coronavirus Activity That Effectively Inhibit Major COVID-19 Variants of Concern (VOCs) in Pseudovirus-Based Assays.

Discovery of Highly Potent Fusion Inhibitors with Potential Pan-Coronavirus Activity That Effectively Inhibit Major COVID-19 Variants of Concern (VOCs) in Pseudovirus-Based Assays.

Journal: Viruses

Published: November 22, 2021

Showing 1-12 of 27

Last Updated: 09/26/2026